维持性血液透析的2型糖尿病肾病患者并发肌少症的相关因素分析
收稿日期: 2023-08-03
网络出版日期: 2024-07-08
基金资助
2019年度新乡市科技攻关计划项目(GG2019032);2023年度河南省医学科技攻关计划项目(LHGJ20230874)
Analysis of related factors of sarcopenia in type 2 diabetic nephropathy patients on maintenance hemodialysis
Received date: 2023-08-03
Online published: 2024-07-08
目的：分析维持性血液透析(maintenance hemodialysis, MHD)的2型糖尿病肾病患者并发肌少症的相关因素，以减少肌少症的发生率。方法：回顾性收集2021年9月至2023年4月在新乡医学院附属人民医院血液净化中心行MHD合并肌少症的237例患者的临床资料。将患者分为2型糖尿病肾病组(100例)和非糖尿病肾病组(137例)，比较2组患者的临床资料及生物电阻抗法(bioelectrical impedance analysis, BIA)结果。以多因素Logistic回归模型分析影响MHD糖尿病肾病患者并发肌少症的相关因素。结果：2组间性别、空腹血糖、血清肌酐、白蛋白、前白蛋白、25-羟维生素D、体质量指数(body mass index，BMI)、体脂肪量(fat mass,FM)、上臂围(arm circumference, AC)、内脏脂肪面积(visceral fat area, VFA)、50 kHz相位角差异均有统计学意义（均P<0.05）。多因素Logistic 回归分析结果显示，性别、空腹血糖、白蛋白、BMI为MHD糖尿病肾病患者并发肌少症的影响因素(OR=0.372、1.350、0.925、1.451,均P<0.05)。结论：MHD的糖尿病肾病患者中男性、低白蛋白血症、高血糖和高BMI者更易并发肌少症。
武梦梦, 杨福燕, 刘雨辰, 鲁旭柯, 高静歌, 叶紫灵 . 维持性血液透析的2型糖尿病肾病患者并发肌少症的相关因素分析[J]. 内科理论与实践, 2024 , 19(02) : 102 -106 . DOI: 10.16138/j.1673-6087.2024.02.03
Objective To analyze related factors of sarcopenia in type 2 diabetic nephropathy patients on maintenance hemodialysis (MHD), in order to reduce the incidence of sarcopenia. Methods The clinical data of 237 patients with MHD complicated with sarcopenia were collected from the Blood Purification Center of the Affiliated People’s Hospital of Xinxiang Medical College from September 2021 to April 2023 retrospectively and analyzed. The patients were divided into type 2 diabetic nephropathy group (100 cases) and non-diabetic nephropathy group (137 cases), and the clinical data and the result of bioelectrical impedance analysis (BIA) were compared between the two groups. Multivariate Logistic regression model was used to analyze the related factors affecting sarcopenia in MHD patients with diabetic nephropathy. Results There were significant differences in gender, fasting blood glucose, serum creatinine, albumin, prealbumin, 25-hydroxyvitamin D, body mass index (BMI), fat mass (FM), arm circumference (AC), visceral fat area (VFA) and 50 kHz phase angle between the two groups(all P<0.05). Multivariate Logistic regression analysis showed that gender, fasting blood glucose, albumin and BMI were independent influencing factors of sarcopenia in MHD diabetic nephropathy patients (odds ratio =0.372, 1.350, 0.925, 1.451, all P<0.05). Conclusions Male, hypoalbuminemia, hyperglycemia and high BMI patients with MHD are more likely to have sarcopenia among diabetic nephropathy patients with MHD.
| [1] | 吴晗, 王丽丽, 王永俊. 维持性血液透析患者肌少症营养干预的研究进展[J]. 山东医药, 2022, 62(25): 108-111. |
| [2] | Cruz-Jentoft AJ, Sayer AA. Sarcopenia[J]. Lancet, 2019, 393(10191):2636-2646. |
| [3] | Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018[J]. Am J Kidney Dis, 2018, 71(6):884-895. |
| [4] | Hou JH, Zhu HX, Zhou ML, et al. Changes in the spectrum of kidney diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China[J]. Kidney Dis (Basel), 2018, 4(1):10-19. |
| [5] | Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3):300-307. |
| [6] | 李兰, 温贤秀, 夏琪, 等. 维持性血液透析患者肌少症患病率的meta分析[J]. 现代预防医学, 2021, 48(22): 4214-4218. |
| [7] | Lai S, Muscaritoli M, Andreozzi P, et al. Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy[J]. Nutrition, 2019,62:108-114. |
| [8] | Fung FY, Koh YLE, Malhotra R, et al. Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting[J]. BMC Geriatr, 2019, 19(1):122. |
| [9] | Feng L, Gao Q, Hu K, et al. Prevalence and risk factors of sarcopenia in patients with diabetes[J]. J Clin Endocrinol Metab, 2022, 107(5):1470-1483. |
| [10] | ?eliker M, Sel?uk MY, Olt S. Sarcopenia in diabetic nephropathy[J]. Rom J Intern Med, 2018, 56(2):102-108. |
| [11] | Tabara Y, Kohara K, Okada Y, et al. Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults[J]. Clin Nutr, 2020, 39(6):1857-1862. |
| [12] | Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association[J]. Diabetes Care, 2017, 40(1):136-154. |
| [13] | Marathe CS, Rayner CK, Jones KL, et al. Novel insights into the effects of diabetes on gastric motility[J]. Expert Rev Gastroenterol Hepatol, 2016, 10(5):581-593. |
| [14] | 薛雨婷. 血清25(OH)维生素D水平与2型糖尿病肾病进展关系的临床研究[D]. 南昌大学医学部, 2023. |
| [15] | Zeng Y, Xu Y, Zhang B, et al. Clinical prognostic role of bioimpedance phase angle in diabetic and non-diabetic hemodialysis patients[J]. Asia Pac J Clin Nutr, 2022, 31(4):619-625. |
| [16] | Herman-Edelstein M, Scherzer P, Tobar A, et al. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy[J]. J Lipid Res, 2014, 55(3): 561-572. |
| [17] | Izzo A, Massimino E, Riccardi G, et al. A narrative review on sarcopenia in type 2 diabetes mellitus[J]. Nutrients, 2021, 13(1):183. |
| [18] | 姜垣, 李强, 肖琳, 等. 中国烟草流行与控制[J]. 中华流行病学杂志, 2011, 32(12): 1181-1187. |
| [19] | Locquet M, Bruyère O, Lengelé L, et al. Relationship between smoking and the incidence of sarcopenia: the SarcoPhAge cohort[J]. Public Health, 2021,193: 101-108. |
| [20] | Shigehara K, Kato Y, Izumi K, et al. Relationship between testosterone and sarcopenia in older-adult men[J]. J Clin Med, 2022, 11(20):6202. |
| [21] | Romejko K, Rymarz A, Sadownik H, et al. Testosterone deficiency as one of the major endocrine disorders in chronic kidney disease[J]. Nutrients, 2022, 14(16):3438. |
| [22] | Kalyani RR, Metter EJ, Egan J, et al. Hyperglycemia predicts persistently lower muscle strength with aging[J]. Diabetes Care, 2015, 38(1):82-90. |
| [23] | 吕娜. 身体质量指数与中老年糖尿病肾病患者临床表现及预后的相关性研究[D]. 苏州大学, 2019. |
| [24] | 魏永梅, 张玉婷. 尿糖、尿微量白蛋白、血清超敏C反应蛋白与糖尿病肾病严重程度的相关性分析[J]. 中国实用医药, 2023, 18(5): 58-61. |
/
| 〈 |
|
〉 |
